Three of the most prominently altered RTK pathways in gliomas include the Ras/MAPK, PI3K/Akt/PTEN, and FAK/Src pathways, all of which rely on adaptor proteins such as Grb2 and Shc to relay the signals from the cell membrane. Here, PTK2 is linked to central nervous system cancer.